Have YOU Signed the Petitions?

We’re encouraging folks to sign two new petitions in support of H.R. 4190 that have just been opened by APhA members Sandra Leal and Steve Soman. As you may already be aware, Reps. Brett Guthrie (R-KY), G.K. Butterfield (D-NC), and Todd Young (R-IN) on March 11 introduced legislation that would enable patient access to, and […]

Continue reading "Have YOU Signed the Petitions?"

Another Successful Year

Post-Graduate Training Residencies and Fellowships Our students continue to be highly successful candidates for post-graduate training in residencies and fellowships. Overall, 22% of the graduating class is pursuing post-graduate training.  This year 82% of URI pharmacy students who applied for PGY1 residencies matched with ASHP-accredited PGY1 programs compared to the national match rate of 64%.  […]

Continue reading "Another Successful Year"

Newsletter – Winter 2014 – Special Edition – Celebrating Research

This issue affords a special focus on the scientific exploration and scholarly work that our faculty and students are engaged in. While the College is known for the quality of its teaching in the pharmaceutical and clinical sciences, the underpinning of that excellence is found in the research conducted by our scientists and clinicians.

Continue reading "Newsletter – Winter 2014 – Special Edition – Celebrating Research"

Opioids: Addiction, Overdose Prevention (Naloxone) and Patient Education

Continuing Professional Development Office of Continuing Professional Development Home Study Program Opioids: Addiction, Overdose Prevention (Naloxone) and Patient Education   Register Here   Opioid abuse and overdose is a growing problem in the United States and in Rhode Island. Pharmacists can play a role in ensuring the safe use of opioids and preventing opioid overdose. […]

Continue reading "Opioids: Addiction, Overdose Prevention (Naloxone) and Patient Education"

Paul Hasting '84, CEO of OncoMed Pharmaceuticals, Inc. to ring the Closing NASDAQ Bell Today

February 7, 2014 – OncoMed Pharmaceuticals, Inc. [OMED], a clinical-stage company developing novel therapeutics that target cancer stem cells (CSCs), or tumor-initiating cells, will visit the NASDAQ MarketSite in Times Square. In honor of the occasion, Paul J. Hastings, Chairman & CEO, will ring the Closing Bell. Paul is a 1984 Alum of the College of […]

Continue reading "Paul Hasting '84, CEO of OncoMed Pharmaceuticals, Inc. to ring the Closing NASDAQ Bell Today"

Dean's Message

| Next Article > Dean’s Message Once again, welcome to the University of Rhode Island College of Pharmacy newsletter in our new “web-friendly” format.  While we strive to provide you with the latest information about your College, there is generally a unifying theme to tie things together.  I am excited to share our Winter 2014 […]

Continue reading "Dean's Message"

Bolstering a Link Between Alzheimer’s Disease and Lead Exposure

< Previous Article | Next Article > Bolstering a Link Between Alzheimer’s Disease and Lead Exposure Lifelong Hazard Researchers striving to understand the origins of dementia are building the case against a possible culprit: lead exposure early in life. A study spanning 23 years has now revealed that monkeys who drank a lead-rich formula as […]

Continue reading "Bolstering a Link Between Alzheimer’s Disease and Lead Exposure"